港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

派格生物醫藥-B

8.830

+0.0100.11%

成交量：4,099.26萬

成交額：3.78億

市值：34.53億

市盈率：-13.88

高：10.480

開：9.260

低：8.430

收：8.820

52周最高：77.000

52周最低：7.460

股本：3.91億

香港流通股本：2.84億

量比：1.75

換手率：14.43%

股息：- -

股息率：- -

每股收益(LYR):-0.636

淨資產收益率：-82.42%

總資產收益率：-31.46%

市淨率：6.66

市盈率(LYR):-13.88

市銷率: -770.32

資料載入中...

總覽公司新聞資訊公告

異動解讀 | 基石投資者延長禁售期彰顯信心，派格生物醫藥-B盤中大漲近19%

派格生物醫藥－Ｂ(02565)股價顯著上升12.338%，現價港幣$27.68

阿斯达克财经

派格生物醫藥－Ｂ(02565)股價下跌5.041%，現價港幣$25.24

阿斯达克财经

異動解讀 | 基石投資者延長禁售期彰顯信心，核心管線進展受關注，派格生物醫藥-B盤中大漲10.69%

派格生物醫藥-B（02565）2025年經營虧損收窄至2.06億元，核心產品推進帶動研發與商業化佈局

派格生物醫藥(02565.HK)基石投資者禁售期延至下月20日

阿斯达克财经

一周港股牛熊榜 | MANYCORE TECH升逾53%領跑，滬上阿姨、博泰車聯強勢爆發；輕鬆健康暴瀉67%領跌，諾比侃、派格生物同步走弱

老虎资讯综合

《全日速報》恒指全日收報26,487點升126點; 恒生科技指數全日收報5,061點跌4點寧德時代升逾4% 建行、寧德時代、工行、中行、富智康集團創新高成交暢旺

阿斯达克财经

一周港股牛熊榜 | 迅策周漲56%、滴普科技飆52%；穩定幣牌照催化，國泰君安國際升31%

老虎资讯综合

派格生物醫藥-B(02565)：中國證監會就本公司H股全流通申請發出備案通知書

派格生物醫藥-B更新3月股份變動月報表，股本維持穩定

GLP-1長效化又有新看點：派格生物(02565)CR059入選ADA LBA 月度給藥潛力受到關注

派格生物醫藥(02565.HK)創新候選產品CR059入選ADA最新突破性摘要

阿斯达克财经

一針管數月，美國學術界都服了：派格生物(02565)新藥CR059登頂ADA，月/季給藥開啓代謝病治療新時代

派格生物醫藥-B(02565):CR059相關研究摘要獲美國糖尿病協會2026年科學年會接收併入選最新突破性摘要

派格生物醫藥-B(02565)：郭恩廷獲委任為聯席公司秘書、授權代表及法律程序代理人

派格－Ｂ（五十）(02565)出現大手賣出15.65萬股，成交價$52.2，涉資816.93萬

阿斯达克财经

派格生物醫藥-B(02565)發布年度業績研發開支5038.7萬元已成功構建覆蓋七款針對慢性疾病領域的在研藥物管線矩陣

派格生物醫藥－Ｂ(02565)股價下跌5.126%，現價港幣$56.45

阿斯达克财经

派格生物醫藥-B升逾10%

每日经济新闻

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02565/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"派格生物醫藥-B","latestPrice":8.83,"timestamp":1779955711008,"preClose":8.82,"halted":0,"volume":40992550,"delay":0,"changeRate":0.001133786848072538,"floatShares":284000000,"shares":391000000,"eps":-0.6361742216511806,"marketStatus":"未開盤","change":0.01,"latestTime":"05-28 16:08:31","open":9.26,"high":10.48,"low":8.43,"amount":377971383,"amplitude":0.232426,"askPrice":8.83,"askSize":65000,"bidPrice":8.82,"bidSize":40050,"shortable":3,"etf":0,"ttmEps":-0.6361742216511806,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1780018200000},"marketStatusCode":0,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":8.82,"openAndCloseTimeList":[[1779931800000,1779940800000],[1779944400000,1779955200000]],"volumeRatio":1.752982,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":284000000,"roa":"-31.46%","roe":"-82.42%","lyrEps":-0.636144,"volumeRatio":1.752982,"shares":391000000,"dividePrice":0,"high":10.48,"amplitude":0.232426,"preClose":8.82,"low":8.43,"week52Low":7.46,"pbRate":"6.66","psRate":"-770.32","week52High":77,"institutionHeld":0,"latestPrice":8.83,"committee":-0.237506,"eps":-0.6361440591654784,"divideRate":0,"volume":40992550,"delay":0,"ttmEps":-0.6361440591654784,"open":9.26,"prevYearClose":69,"prevWeekClose":12.94,"prevMonthClose":24.64,"prevQuarterClose":58,"fiveDayClose":15.38,"twentyDayClose":26.38,"sixtyDayClose":64.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2026-03-23","symbol":"02565","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-26","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2026-05-27","current":-13.89729,"percent":0.869198,"low":-87.782868,"twenty":-73.777626,"median":-61.31588,"eighty":-19.117647,"high":-11.114373,"avg":-52.767999,"sd":24.924517,"marketCap":3449427312},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426},{"date":"2025-06-06","current":-11.987888,"twenty":-13.726785,"median":-12.740515,"eighty":-12.114178,"marketCap":3712892217},{"date":"2025-06-13","current":-11.23576,"twenty":-13.295707,"median":-12.114337,"eighty":-11.528404,"marketCap":3481318898},{"date":"2025-06-20","current":-11.30775,"twenty":-12.841258,"median":-11.963331,"eighty":-11.337793,"marketCap":3496757119},{"date":"2025-06-27","current":-12.421214,"twenty":-12.738977,"median":-11.541778,"eighty":-11.292079,"marketCap":3851836209},{"date":"2025-07-04","current":-13.963875,"twenty":-12.971799,"median":-11.987888,"eighty":-11.299391,"marketCap":4330421069},{"date":"2025-07-11","current":-13.604213,"twenty":-13.050401,"median":-12.199189,"eighty":-11.305737,"marketCap":4214634409},{"date":"2025-07-18","current":-16.956264,"twenty":-13.748078,"median":-12.438987,"eighty":-11.330282,"marketCap":5248995235},{"date":"2025-07-25","current":-19.006677,"twenty":-15.472199,"median":-12.742066,"eighty":-11.352726,"marketCap":5905119639},{"date":"2025-08-01","current":-19.199848,"twenty":-18.276271,"median":-12.906561,"eighty":-11.424474,"marketCap":5928276971},{"date":"2025-08-08","current":-20.51103,"twenty":-19.019895,"median":-13.05938,"eighty":-11.472546,"marketCap":6348968501},{"date":"2025-08-15","current":-39.959751,"twenty":-19.179784,"median":-13.542645,"eighty":-11.515029,"marketCap":12350577024},{"date":"2025-08-22","current":-41.864246,"twenty":-19.284777,"median":-13.964282,"eighty":-11.779976,"marketCap":12898633879},{"date":"2025-08-29","current":-41.44792,"twenty":-21.432837,"median":-14.946806,"eighty":-11.968242,"marketCap":10033166343},{"date":"2025-09-05","current":-50.678037,"twenty":-39.039264,"median":-17.018603,"eighty":-12.06328,"marketCap":12255314482},{"date":"2025-09-12","current":-58.538001,"twenty":-40.749762,"median":-18.438762,"eighty":-12.114019,"marketCap":14181548421},{"date":"2025-09-19","current":-57.311117,"twenty":-43.720929,"median":-18.952908,"eighty":-12.216159,"marketCap":13874467648},{"date":"2025-09-26","current":-63.587749,"twenty":-49.33228,"median":-19.070122,"eighty":-12.366345,"marketCap":15354038645},{"date":"2025-10-03","current":-60.149194,"twenty":-54.575673,"median":-19.16943,"eighty":-12.428323,"marketCap":14558420278},{"date":"2025-10-10","current":-60.121463,"twenty":-57.957283,"median":-19.199848,"eighty":-12.49878,"marketCap":14530503844},{"date":"2025-10-17","current":-60.168303,"twenty":-59.756564,"median":-19.2984,"eighty":-12.738571,"marketCap":14530503844},{"date":"2025-10-24","current":-61.301982,"twenty":-60.143648,"median":-20.51103,"eighty":-12.741458,"marketCap":14809668183},{"date":"2025-10-31","current":-69.345185,"twenty":-60.159469,"median":-22.018639,"eighty":-12.743079,"marketCap":16777776773},{"date":"2025-11-07","current":-59.401661,"twenty":-60.392128,"median":-34.33922,"eighty":-12.780248,"marketCap":14363005241},{"date":"2025-11-14","current":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"marketCap":17657144441},{"date":"2025-11-21","current":-72.852961,"twenty":-61.301982,"median":-40.866122,"eighty":-12.943343,"marketCap":17657144441},{"date":"2025-11-28","current":-82.344376,"twenty":-62.346137,"median":-42.423494,"eighty":-13.014482,"marketCap":20030041323},{"date":"2025-12-05","current":-72.063717,"twenty":-63.355663,"median":-45.122001,"eighty":-13.104279,"marketCap":17559436923},{"date":"2025-12-12","current":-74.217813,"twenty":-64.460997,"median":-48.969529,"eighty":-13.233973,"marketCap":18117765601},{"date":"2025-12-19","current":-71.875632,"twenty":-65.413889,"median":-52.055133,"eighty":-13.542645,"marketCap":17587353357},{"date":"2025-12-24","current":-73.927127,"twenty":-69.382811,"median":-55.337969,"eighty":-13.579586,"marketCap":18145682035},{"date":"2026-01-02","current":-79.895405,"twenty":-70.540926,"median":-57.311117,"eighty":-13.748078,"marketCap":19687798475},{"date":"2026-01-09","current":-85.854057,"twenty":-72.056904,"median":-58.941314,"eighty":-13.964201,"marketCap":21208805289},{"date":"2026-01-16","current":-80.413876,"twenty":-72.839385,"median":-59.401661,"eighty":-14.164153,"marketCap":19929453763},{"date":"2026-01-23","current":-77.735339,"twenty":-73.262106,"median":-59.808211,"eighty":-14.656731,"marketCap":19247132950},{"date":"2026-01-30","current":-73.838267,"twenty":-73.550435,"median":-60.0941,"eighty":-15.472199,"marketCap":18365801899},{"date":"2026-02-06","current":-69.490034,"twenty":-73.32273,"median":-60.154331,"eighty":-16.538679,"marketCap":17328105662},{"date":"2026-02-13","current":-71.473742,"twenty":-73.562339,"median":-60.192909,"eighty":-17.006135,"marketCap":17925136373},{"date":"2026-02-20","current":-71.065981,"twenty":-73.716985,"median":-60.392128,"eighty":-17.056006,"marketCap":17797201221},{"date":"2026-02-27","current":-72.540901,"twenty":-73.438012,"median":-60.796223,"eighty":-17.950543,"marketCap":18365801899},{"date":"2026-03-06","current":-68.036226,"twenty":-73.352041,"median":-61.160082,"eighty":-18.384598,"marketCap":17086450373},{"date":"2026-03-13","current":-60.794114,"twenty":-73.299371,"median":-60.919795,"eighty":-18.597951,"marketCap":15338003289},{"date":"2026-03-20","current":-67.303035,"twenty":-73.275932,"median":-61.206433,"eighty":-18.84686,"marketCap":16915870170},{"date":"2026-03-27","current":-68.867925,"twenty":-73.269478,"median":-61.274827,"eighty":-18.985169,"marketCap":16247764373},{"date":"2026-04-02","current":-85.055535,"twenty":-73.278872,"median":-61.433108,"eighty":-19.026504,"marketCap":20163286400},{"date":"2026-04-10","current":-78.454069,"twenty":-73.369897,"median":-61.662876,"eighty":-19.045802,"marketCap":18741784705},{"date":"2026-04-17","current":-76.94604,"twenty":-73.948705,"median":-62.45145,"eighty":-19.079188,"marketCap":18389252284},{"date":"2026-04-24","current":-60.4786,"twenty":-73.948705,"median":-62.528681,"eighty":-19.126247,"marketCap":14454535592},{"date":"2026-05-15","current":-17.642518,"twenty":-73.927127,"median":-62.346137,"eighty":-19.115451,"marketCap":4376314243},{"date":"2026-05-22","current":-20.448357,"twenty":-73.838267,"median":-61.433108,"eighty":-19.16943,"marketCap":5060724424},{"date":"2026-05-27","current":-13.89213,"twenty":-73.777626,"median":-61.31588,"eighty":-19.117647,"marketCap":3449427312}],"updateTime":1779969672392},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1119189720","title":"異動解讀 | 基石投資者延長禁售期彰顯信心，派格生物醫藥-B盤中大漲近19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119189720","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119189720?lang=zh_tw&edition=fundamental","pubTime":"2026-05-05 16:17","pubTimestamp":1777969049,"startTime":"0","endTime":"0","summary":"派格生物医药-B今日盘中大幅上涨，涨幅一度达到18.91%，表现异常强劲。消息面上，此次股价异动与公司近期公布的一则消息密切相关。派格生物医药宣布，其基石投资者已同意自愿延长禁售期，在原定期满日后，直至5月20日期间不会以任何方式减持所持股份。分析指出，派格生物医药是国内少数能够实现药用聚乙二醇原料自主生产，并将其整合应用于慢性疾病药物全流程开发的企业。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633976209","title":"派格生物醫藥－Ｂ(02565)股價顯著上升12.338%，現價港幣$27.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2633976209","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633976209?lang=zh_tw&edition=fundamental","pubTime":"2026-05-05 15:05","pubTimestamp":1777964700,"startTime":"0","endTime":"0","summary":"[上升股]派格生物医药－Ｂ(02565) 股价在下午03:05比前收市价显著上升12.338%，现股价为港币$27.68。至目前为止，今日最高价为$27.68，而最低价为$24.1。总成交量为158.59万股，总成交金额为港币$4.139千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2605052404/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2605052404/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02565","BK1161","161726","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631509419","title":"派格生物醫藥－Ｂ(02565)股價下跌5.041%，現價港幣$25.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2631509419","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631509419?lang=zh_tw&edition=fundamental","pubTime":"2026-04-30 13:30","pubTimestamp":1777527000,"startTime":"0","endTime":"0","summary":"[下跌股]派格生物医药－Ｂ(02565) 股价在下午01:30比前收市价下跌5.041%，现股价为港币$25.24。至目前为止，今日最高价为$27.14，而最低价为$25.24。总成交量为13.905万股，总成交金额为港币$359.934万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2604304001/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2604304001/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["399441","161726","BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169148870","title":"異動解讀 | 基石投資者延長禁售期彰顯信心，核心管線進展受關注，派格生物醫藥-B盤中大漲10.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169148870","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169148870?lang=zh_tw&edition=fundamental","pubTime":"2026-04-29 13:52","pubTimestamp":1777441979,"startTime":"0","endTime":"0","summary":"派格生物医药-B(02565)今日盘中大涨10.69%，引起了市场的广泛关注。消息面上，公司基石投资者同意自愿延长禁售期，从原定届满日起至5月20日不会减持任何持股。公司表示，此举表明基石投资者基于公司在技术研发能力及重大临床里程碑方面取得的进展，对公司的未来前景充满信心。此外，派格生物的核心管线CR059入选美国糖尿病协会科学年会Late Breaking Abstract，再度将市场目光聚焦于其circRNA-LNP技术平台。作为专注于代谢疾病领域的创新药企业，CR059所代表的超长效GLP-1技术路径，正在为市场带来新的想象空间。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159552360","title":"派格生物醫藥-B（02565）2025年經營虧損收窄至2.06億元，核心產品推進帶動研發與商業化佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=1159552360","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159552360?lang=zh_tw&edition=fundamental","pubTime":"2026-04-28 22:05","pubTimestamp":1777385139,"startTime":"0","endTime":"0","summary":"派格生物医药医药（杭州）股份有限公司专注于慢性疾病和代谢性疾病创新生物药的研究和开发，主要聚焦2型糖尿病、非酒精性脂肪肝炎以及阿片类药物引起的便秘等领域。公司研发开支为人民币0.50亿元，较上一年度的人民币0.95亿元下降47.2%，主要原因在于核心产品进入后期研发与商业化筹备阶段后，相关投入结构随研发进度而有所调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"派格生物医药-B（02565）2025年经营亏损收窄至2.06亿元，核心产品推进带动研发与商业化布局","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630588146","title":"派格生物醫藥(02565.HK)基石投資者禁售期延至下月20日","url":"https://stock-news.laohu8.com/highlight/detail?id=2630588146","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630588146?lang=zh_tw&edition=fundamental","pubTime":"2026-04-28 21:45","pubTimestamp":1777383900,"startTime":"0","endTime":"0","summary":"派格生物医药－Ｂ(02565.HK) 公布，基石投资者同意自愿禁售期届满日(即4月301)起至5月20日不会以任何方式减持任何持股。目前，基石投资者合共持有958.45万股，占H股总股本3.37%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-04-28 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250605144834237_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250605144834237_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1521070/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1521070/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["161726","02565","399441","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143173819","title":"一周港股牛熊榜 | MANYCORE TECH升逾53%領跑，滬上阿姨、博泰車聯強勢爆發；輕鬆健康暴瀉67%領跌，諾比侃、派格生物同步走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1143173819","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143173819?lang=zh_tw&edition=fundamental","pubTime":"2026-04-24 18:11","pubTimestamp":1777025517,"startTime":"0","endTime":"0","summary":"MANYCORE TECH于4月17日登陆港交所，发行价7.62港元，上市首日升超180%。该股近7个交易日累计升幅超102%。4月22日股价大涨25.15%，较40港元招股价升幅突破200%，创上市新高。公司今年以来累计跌幅已达57.39%，市值持续缩水引发抛压。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02589","02565","02889","02575","02661","01384","02635","06636","02632","00068"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2629861590","title":"《全日速報》恒指全日收報26,487點 升126點; 恒生科技指數全日收報5,061點 跌4點 寧德時代升逾4% 建行、寧德時代、工行、中行、富智康集團創新高 成交暢旺","url":"https://stock-news.laohu8.com/highlight/detail?id=2629861590","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629861590?lang=zh_tw&edition=fundamental","pubTime":"2026-04-21 16:12","pubTimestamp":1776759120,"startTime":"0","endTime":"0","summary":"恒指全日收26,487点，升126点或0.5%。恒生科技指数报5,061点，跌4点或0.1%。国指升44点或0.5%，报8,943点。大市成交额2,051.77亿元。沽空资料截至 2026-04-21 12:25。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180305131111145_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180305131111145_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1519099/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1519099/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0516422952.EUR","00325","LU0049853897.USD","MPNGY","LU0235996351.USD","LU0823426308.USD","LU1242518931.SGD","LU2294711473.HKD","LU0828238088.HKD","LU1997244956.HKD","LU0531971595.HKD","LU2097828805.USD","HSTECH","LU0823414551.USD","BACHY","LU0244354667.USD","LU1242518857.USD","LU1961090484.USD","SG9999003461.SGD","TCEHY","LU0054450605.USD","HKXCY","LU2238339852.HKD","LU0650527681.SGD","LU2360107325.USD","LU0651947912.USD","LU2477742899.HKD","LU0210526637.USD","XIACY","LU1960683339.HKD","CICHY","IE0032431581.USD","LU1993786604.SGD","LU0259732245.USD","LU0724618433.USD","LU2476274308.USD","LU0048580855.USD","09988","LU0128522157.USD","BK1167","LU0543330483.HKD","LU3063872942.SGD","SG9999001846.SGD","00968","LU0327786744.USD","02038","SG9999001689.USD","601939","IDCBY","LU0505663152.USD","IE00BPRC5H50.USD","LU0593848301.USD","LU1868837565.USD","03690","LU0359202008.SGD","LU0611395673.USD","LU2153592121.USD","LU0359201612.USD","LU1770034418.SGD","LU2148510915.USD","LU0880133367.SGD","BK1508","IE00B5MMRT66.SGD","LU0132412106.USD","LU2242644610.SGD","LU2424517915.HKD","LU1721428347.USD","LU0456827905.SGD","LU0067412154.USD","LU1969619763.USD","LU0672654166.SGD","LU0251143458.SGD","LU0043850808.USD","LU0039217434.USD","LU0048388663.USD","LU0328353924.USD","LU2348773727.SGD","02635","LU1655091616.SGD","LU1102505929.USD","IE00B3M56506.USD","LU2092937221.SGD","BK0224","LU2506952253.HKD","LU2360108059.USD","601088","LU0516423091.SGD","LU0029875118.USD","LU0312595415.SGD","LU0449509016.USD","IE0003795394.USD","SG9999002828.SGD","LU0979878070.USD","LU0823437842.USD","LU1328277881.USD","LU0051755006.USD","LU1813983027.USD","LU1939255532.USD","HK0000181138.USD","LU0149534421.HKD","IE00B8HQ1Z84.USD","LU1880383366.USD","LU0106259558.USD","BK1116","LU0231483743.USD","HK0000181112.HKD","LU0516423174.USD","IE00BD6J9T35.USD","LU1820825898.SGD","LU1039395188.USD","LU2125910849.SGD","LU2294711713.HKD","LU2506952410.USD","LU0164865239.USD","LU2506952337.HKD","00388","LU0594300179.USD","00939","LU0463099449.HKD","LU1051769294.HKD","LU1303224171.USD","LU0516422366.SGD","LU2097828557.USD","LU1997245177.USD","SG9999002463.SGD","300750","LU0164872284.USD","02565","LU1997245094.SGD","LU1064131003.USD","02589","EVS.SI","LU1023057109.AUD","LU1188198961.HKD","LU1861214812.USD","LU2357125470.USD","LU0821914370.USD","01398","LU1781817850.SGD","HHImain","LU1808992512.USD","LU2449936058.SGD","LU0140636845.USD","LU0605514214.HKD","LU0828237510.HKD","LU2289578879.USD","LU2097828474.EUR","LU0823426480.USD","LU1146622755.USD","LU0502904849.HKD","LU0165289439.USD","LU1152091168.USD","LU2153591404.USD","LU2476274720.SGD","LU0048575426.USD","LU0188438112.USD","IE00B8L5B284.USD","LU0370786039.SGD","LU0106252389.USD","LU2580892789.USD","601988","LU1979443071.USD","LU0607220059.USD","LU0828237940.HKD","LU0326950275.SGD","LU0455707207.USD","LU0011963245.USD","LU0651946864.USD","LU0501845795.SGD","LU1769817179.HKD","IE00B543WZ88.USD","LU1048588211.SGD","LU0269904917.USD","LU0348805143.USD","LU0531970944.HKD","LU2097828631.EUR","LU0254981946.USD","LU2298064838.USD","IE0003851619.USD","FXCNY","LU2041044095.USD","LU0314109678.HKD","LU1102505762.USD","LU0228659784.USD","LU0326948709.USD","MCHmain","SGXZ49509284.SGD","LU2580892862.HKD","BK1610","LU1255011170.USD","LU1580142542.USD","LU0261950470.USD","LU1880383440.USD","LU1008478684.HKD","LU0572944931.SGD","LU2328871848.SGD","03750","LU1719994722.HKD","03988","LU1978683503.SGD","LU0107464264.USD","LU1831875114.USD","LU1515016050.SGD","LU0192582467.USD","LU0124384867.USD","IE00BZ199S13.USD","BK1504","LU0143863198.USD","LU2298322129.HKD","IE00B29SXG58.USD","SG9999000459.SGD","LU2039709279.SGD","LU0072913022.USD","SG9999001903.USD","601398","LU1861219969.SGD","01088","LU2097828714.EUR","LU1720050803.USD","LU2399975544.HKD","LU0594300419.USD","HSI","513600","LU2045819591.USD","CSUAY","LU0106959298.USD","LU1769817096.USD","BABA","LU2778985437.USD","LU1051768304.USD","LU0449515922.USD","SGXZ81163826.USD","02057","LU0320764755.SGD","LU0359201885.HKD","LU2125910500.SGD","LU0405327494.USD","LU2495084118.USD","01810","LU1251922891.USD","LU0181495838.USD","LU2152927971.USD","SG9999000327.SGD","LU0871576103.HKD","LU1807302812.USD","LU0823414478.USD","00700","LU0214875030.USD","LU0302445910.USD","LU1934453819.USD","LU0516422440.USD","LU0405327148.USD","LU0469268626.HKD","LU1152091754.HKD","LU0509642566.USD","LU1868838027.USD","LU1794554557.SGD","LU0047713382.USD","LU2249611893.SGD","LU1048596156.SGD","LU1064130708.USD","02833","LU0072462343.USD","LU2348774022.SGD","LU2394011477.USD","LU2298321311.HKD","LU0143863784.USD","LU2506951792.HKD","LU2275660780.HKD","ZTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174752895","title":"一周港股牛熊榜 | 迅策周漲56%、滴普科技飆52%；穩定幣牌照催化，國泰君安國際升31%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174752895","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174752895?lang=zh_tw&edition=fundamental","pubTime":"2026-04-10 16:47","pubTimestamp":1775810821,"startTime":"0","endTime":"0","summary":"近期港股市场整体活跃，多只中小市值个股创阶段新高，而怡俊集团控股亦成为资金关注对象之一。TCL电子本周升幅29.85%消息面上，公司近期发布 2025年全年业绩，业绩表现强劲，成为股价上涨的重要催化。业绩公布后，市场反应积极，股价一度 大涨超过10%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01384","03033","HSI","03317","01788","HSTECH","09903","01530","03668","02889","02656","03625","02565"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2626821185","title":"派格生物醫藥-B(02565)：中國證監會就本公司H股全流通申請發出備案通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2626821185","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626821185?lang=zh_tw&edition=fundamental","pubTime":"2026-04-09 18:27","pubTimestamp":1775730460,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B(02565)发布公告，本公司已收到中国证监会就实施H股全流通而发出日期为2026年3月26日的备案通知书。根据备案通知书，本公司就合计1.02亿股未上市股份实施H股全流通向中国证监会作出的备案已经完成。倘自备案通知书日期起计12个月内未完成股份转换，且本公司仍有意进行该转换，则本公司应当向中国证监会更新备案材料。本公司将向联交所申请批准该等H股于联交所主板上市及买卖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399441","02565","BK4581","BK4588","BK4585","XBI","BK1161","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129396776","title":"派格生物醫藥-B更新3月股份變動月報表，股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1129396776","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129396776?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 17:15","pubTimestamp":1775639734,"startTime":"0","endTime":"0","summary":"派格生物医药(杭州)股份有限公司于2026年4月8日发布了截至2026年3月31日的月度股份变动报告。报告显示，公司本月未有新增发行、购回或注销活动，股本结构保持稳定。\n根据公告，截至报告期末，公司已发行的H股数量为284,300,339股，非上市股份数量为106,791,193股，公司注册股本总额为人民币391,091,532元，均与上月保持一致。报告同时指出，公司无股份期权、可换股票据或其他股份激励工具的新增或行使情况。\n公告显示，公司确认符合香港联交所《上市规则》有关维持足够公众持股量的要求。上述信息由联席公司秘书黄一峰签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625932346","title":"GLP-1長效化又有新看點：派格生物(02565)CR059入選ADA LBA 月度給藥潛力受到關注","url":"https://stock-news.laohu8.com/highlight/detail?id=2625932346","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625932346?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 19:00","pubTimestamp":1775559600,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，派格生物近期凭借核心管线CR059入选美国糖尿病协会科学年会Late Breaking Abstract，再度把市场目光拉回到其circRNA-LNP技术平台上。circRNA-LNP技术：跳出传统GLP-1长效化思路的新尝试派格生物CR059的核心看点，来自其自主研发的circRNA-LNP技术平台。总体来看，派格生物这次因CR059入选ADA LBA而受到关注，并不只是因为拿到了一个学术会议席位，更因为它把公司在GLP-1长效化方向上的技术路线，再次推到了聚光灯下。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","GLP","02565","BK4590","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625084931","title":"派格生物醫藥(02565.HK)創新候選產品CR059入選ADA最新突破性摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2625084931","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625084931?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 18:20","pubTimestamp":1775557200,"startTime":"0","endTime":"0","summary":"派格生物医药－Ｂ(02565.HK) 公布，集团自主研发的创新候选产品CR059相关研究摘要获美国糖尿病协会(ADA)2026年科学年会接收，并入选最新突破性摘要，将以海报形式展示。根据相关研究结果，CR059展现出显著减重效果、突出的降糖表现及长期表达特征，并显示出作为长效代谢疾病治疗方案的开发潜力。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-04-02 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220210100852532_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220210100852532_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1515985/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1515985/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02565","399441","BK1161","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624160506","title":"一針管數月，美國學術界都服了：派格生物(02565)新藥CR059登頂ADA，月/季給藥開啓代謝病治療新時代","url":"https://stock-news.laohu8.com/highlight/detail?id=2624160506","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624160506?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 19:59","pubTimestamp":1775131190,"startTime":"0","endTime":"0","summary":"派格生物CR059入选ADA2026最新突破性摘要，是公司研发历程中的重要里程碑，也是全球GLP-1领域的重大突破。circRNA技术平台赋予了CR059月/季给药的颠覆性优势，有望开启代谢病治疗的全新时代，为全球数亿患者带来更便捷的治疗选择。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624503214","title":"派格生物醫藥-B(02565):CR059相關研究摘要獲美國糖尿病協會2026年科學年會接收併入選最新突破性摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2624503214","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624503214?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 19:15","pubTimestamp":1775128554,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B 发布公告，集团自主研发的创新候选产品CR059 相关研究摘要已获美国糖尿病协会2026年科学年会接收，并入选Late Breaking Abstract，将以海报形式展示。根据相关研究结果，CR059展现出显著减重效果、突出的降糖表现及长期表达特征，并显示出作为长效代谢疾病治疗方案的开发潜力。美国糖尿病协会科学年会是糖尿病及代谢疾病领域具有国际影响力的学术会议之一。根据会议安排，上述研究摘要将于ADA 2026年科学年会期间以海报形式展示。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK4581","161726","399441","BK4588","XBI","BK4585","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624047597","title":"派格生物醫藥-B(02565)：郭恩廷獲委任為聯席公司秘書、授權代表及法律程序代理人","url":"https://stock-news.laohu8.com/highlight/detail?id=2624047597","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624047597?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 19:01","pubTimestamp":1775041287,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B(02565)发布公告，邹醒龙先生(邹先生)已辞任本公司联席公司秘书(联席公司秘书); 香港联合交易所有限公司证券上市规则第 3.05条项下的本公司授权代表(授权代表); 及根据香港法例第622章公司条例第16部代表本公司于香港接收法律程序文件及通知的代表(法律程序代理人)， 自 2026年4月1日起生效。自邹先生辞任联席公司秘书、授权代表及法律程序代理人后，郭恩廷女士(郭女士)已获委任为联席公司秘书、授权代表及法律程序代理人，自2026年4月1日起生效。黄一峰先生(黄先生)将继续担任另一名联席公司秘书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","BK4581","399441","02565","BK1161","XBI","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624055741","title":"派格－Ｂ（五十）(02565)出現大手賣出15.65萬股，成交價$52.2，涉資816.93萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2624055741","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624055741?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 09:00","pubTimestamp":1775005200,"startTime":"0","endTime":"0","summary":"[大手成交]派格－Ｂ（五十）(02565)在上午09:00出现大手卖出，成交量为15.65万，成交价为港币$52.2，涉资816.93万。至目前为止，股价无升跌，今日最高价为$52.2，而最低价为$52.2，总成交量为191.9万股，总成交金额港币$1.002亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2604015/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2604015/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621776330","title":"派格生物醫藥-B(02565)發布年度業績 研發開支5038.7萬元 已成功構建覆蓋七款針對慢性疾病領域的在研藥物管線矩陣","url":"https://stock-news.laohu8.com/highlight/detail?id=2621776330","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621776330?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 16:38","pubTimestamp":1774255101,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B 发布截至2025年12月31日止年度业绩，该集团取得其他净收入18.9万元;研发开支5038.7万元;每股基本亏损0.55元。截至本公告日期，我们在于美国及中国推进技术创新、产品管线及业务营运方面取得重大进展。截至本公告日期，派格生物已成功构建覆盖七款针对慢性疾病领域的在研药物管线矩阵。随着核心产品派达康于2025年11月成功获得上市批准，集团将全面推进其在中国市场的商业化落地工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","399441","BK4581","BK4585","XBI","161726","BK4588","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621726378","title":"派格生物醫藥－Ｂ(02565)股價下跌5.126%，現價港幣$56.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2621726378","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621726378?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 11:00","pubTimestamp":1774234800,"startTime":"0","endTime":"0","summary":"[下跌股]派格生物医药－Ｂ(02565) 股价在上午11:00比前收市价下跌5.126%，现股价为港币$56.45。至目前为止，今日最高价为$62.0，而最低价为$56.45。总成交量为9.75万股，总成交金额为港币$564.715万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603235222/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603235222/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02565","161726","399441","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620209854","title":"派格生物醫藥-B升逾10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620209854","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620209854?lang=zh_tw&edition=fundamental","pubTime":"2026-03-20 10:51","pubTimestamp":1773975087,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月20日，派格生物医药-B(02565.HK)涨超10%，截至发稿，涨10.21%，报61.55港元，成交额2519.24万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603203678545515.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603203678545515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02565","BK4581","BK4588","XBI","399441","BK4585","BK1161","161726"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":98,"code":"91000000","status":"200"}]}}